UK launches initiative to test AI in drug development
UK launches initiative to test AI in drug development
Updated at: June 10, 2026 at 03:00 AM
On June 9, 2026, the UK government launched a landmark initiative to transform drug development through the power of artificial intelligence.
This controlled space allows researchers to collaborate directly with regulators, ensuring that AI-driven tools are safe, accurate, and capable of predicting drug side effects before they reach patients.
The initiative addresses the daunting 90% failure rate in traditional drug development.
